Effect of pilocarpine mouthwash on symptoms and salivary flow rate

Phase 3

Recruiting

• Conditions: xerostomia.; Dry mouth, unspecified; R68.2

• Registration Number: IRCT20200108046050N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

People who have had dry mouth for 3 months or more
People with age between 20 to 60
People who have informed consent to participate in the study

Exclusion Criteria

People with acute asthma attack or narrow-angle glaucoma or acute iris inflammation
Women who are pregnant or breastfeeding
People who have heart disease
People whose dry mouth is caused by radiotherapy to the head and neck

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Salivary flow rate. Timepoint: Before intervention, after 30 minutes and 2 weeks after initiation of pilocarpine mouthwash use. Method of measurement: Measurement of the volume of saliva collected in 5 minutes in a calibrated test tube.;Xerostomia symptoms. Timepoint: Before intervention, after 30 minutes and 2 weeks after initiation of pilocarpine mouthwash use. Method of measurement: Visual Analogue Scale.